WuXi STA Establishes Middletown, Delaware, Pharmaceutical Manufacturing Campus
08/18/2022
Phase I of the new campus will provide formulation development, clinical and commercial drug product manufacturing services for a variety of oral and injectable dosage forms, as well as packaging, labeling, storage and distribution services for clinical trial materials and commercial drug products, according to company officials. Operations are set to begin in 2025.
"I would like to thank our federal, state and local partners in Delaware for their continued support in the establishment of this site," said Dr. Minzhang Chen, co-CEO of WuXi AppTec and CEO of WuXi STA. "WuXi STA continues to increase our capabilities and capacities to better serve our customers through a more robust and reliable supply chain. With our integrated Contract Research, Development, and Manufacturing Organization (CRDMO) platform and proven quality system, we look forward to working with our customers to swiftly deliver their innovative therapies to market in order to save lives and improve healthcare for patients."
First announced in June 2021, this site will be WuXi STA's second facility in the United States, offering expanded capacity and greater flexibility to meet the needs of customers in the U.S. and around the world.
"The biopharmaceutical industry is part of Delaware's DNA," said Delaware Governor John Carney. "Over the next five years, WuXi STA plans to build a state-of-the-art pharmaceutical manufacturing campus in one of Delaware's fastest-growing communities, bringing with it good jobs and economic growth. This campus is only possible because of Delaware's world-class, innovative workforce. Thank you to WuXi STA, Middletown Mayor Kenny Branner and everyone who made this project possible."
WuXi STA has 12 sites across the U.S., Europe and Asia that offer a range of services and meet or exceed all regulatory standards. Together with three other drug product manufacturing sites in Couvet (Switzerland), Wuxi City (China) and Shanghai (China), this new facility will further enhance the company's global drug production capacity and capabilities.
Project Announcements
Baltimore Fabrication Expands York County, Pennsylvania, Manufacturing Operations
07/25/2025
Mueller Streamline Expands Wynne, Arkansas, Manufacturing Operations
07/25/2025
Hive Plastics Plans Iron County, Utah, Manufacturing Operations
07/25/2025
Sigma Stretch Film of Georgia Plans Columbus, Georgia, Operations
07/24/2025
Turkish-Based Kervan USA Expands Lehigh Valley, Pennsylvania, Operations
07/24/2025
Germany-Based Butting Plans Loxley, Alabama, Production Operations
07/24/2025
Most Read
-
20th Annual Area Development Gold and Silver Shovel Awards
Q2 2025
-
In Focus: AI Is Changing Incentives Math
Q2 2025
-
Optimizing Your Rail-Served Transportation Network: Strategy Before Steel
Q2 2025
-
How to Choose the Right Site for Your Factory in 2025’s Volatile Landscape
Q2 2025
-
From Silicon to Server: Mapping the Data Center Supply Chain
Q2 2025
-
Tariffs, Talent, and U.S. Expansion
Q3 2025
-
First Person: David Robey, Co-CEO of QTS Data Centers
Q2 2025